Entry Detail



General Information

Database ID:exR0089543
RNA Name:hsa-miR-185-5p
RNA Type:miRNA
Chromosome:chr22
Starnd:+
Coordinate:
Start Site(bp):20033153End Site(bp):20033174
External Links:hsa-miR-185-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
TFAP2A
chr6
10393186
10419659
-
SSH2
chr17
29625938
29930276
-
ZBTB4
chr17
7459366
7484263
-
CTSA
chr20
45890144
45898820
+
TSPAN14
chr10
80454166
80533124
+
ACVR1B
chr12
51951699
51997078
+
GRB2
chr17
75318076
75405709
-
RAB5A
chr3
19947097
19985175
+
RAB40C
chr16
589357
629272
+
VPS37B
chr12
122865330
122896127
-
SLC29A1
chr6
44219553
44234142
+
NDRG1
chr8
133237171
133302022
-
HDLBP
chr2
241227264
241317061
-
RSU1
chr10
16590611
16817463
-
HADHA
chr2
26190635
26244672
-
VPS4A
chr16
69311350
69326939
+
IGF2BP1
chr17
48997385
49056145
+
NF1
chr17
31094927
31382116
+
SMAD3
chr15
67063763
67195169
+
ORAI1
chr12
121626550
121642677
+
ADGRG1
chr16
57610652
57665580
+
TNRC6B
chr22
40044817
40335808
+
ZMIZ1
chr10
79068966
79316528
+
GOLGA1
chr9
124878275
124948492
-
ZBTB38
chr3
141324213
141449792
+
SLC29A2
chr11
66362521
66372214
-
GATAD2B
chr1
153789030
153923360
-
GBA2
chr9
35736866
35749228
-
OTUD4
chr4
145110838
145180589
-
FAM234A
chr16
234521
272183
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001658
chr6
157357968
157406039
+
hsa_circ_0000711
chr16
68155889
68160513
+
hsa_circ_0001168
chr20
47691321
47707559
+
hsa_circ_0001146
chr20
34241449
34246936
-
hsa_circ_0001164
chr20
45891031
45923523
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007952.4
chr17
19112000
19112636
-
AC008040.1
chr3
169939353
169966734
-
AC021092.1
chr19
44103007
44113183
-
LINC01278
chrX
63222993
63561095
-
MALAT1
chr11
65497688
65506516
+
MIR137HG
chr1
97933474
98049863
-
MIR663AHG
chr20
26167817
26251546
-
NEAT1
chr11
65422774
65445540
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.